(Q43533886)

24 November 2017

CD133 expression: a potential prognostic marker for non-small cell lung cancers (English)

1 reference

24 November 2017

11

1 reference

24 November 2017

Hidenori Mizugaki

1

1 reference

24 November 2017

Jun Sakakibara-Konishi

2

1 reference

24 November 2017

Junko Kikuchi

3

1 reference

24 November 2017

Jun Moriya

4

1 reference

24 November 2017

Kanako C Hatanaka

5

1 reference

24 November 2017

Eiki Kikuchi

6

1 reference

24 November 2017

Ichiro Kinoshita

7

1 reference

24 November 2017

Satoshi Oizumi

8

1 reference

24 November 2017

Hirotoshi Dosaka-Akita

9

1 reference

24 November 2017

Yoshihiro Matsuno

10

1 reference

24 November 2017

12 March 2013

1 reference

International Journal of Clinical Oncology

24 November 2017

1 reference

24 November 2017

19

1 reference

24 November 2017

2

1 reference

24 November 2017

254-259

1 reference

https://scigraph.springernature.com/pub.10.1007/s10147-013-0541-x

24 November 2017

0 references

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0541-X

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0541-X

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0541-X

CD133 expression is an independent prognostic marker for low survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0541-X

Stem cell marker CD133 affects clinical outcome in glioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0541-X

Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0541-X

Tumorigenic stem and progenitor cells: implications for the therapeutic index of anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0541-X

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0541-X

Inconsistent immunohistochemical expression patterns of four different CD133 antibody clones in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0541-X

Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0541-X

CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0541-X

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0541-X

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0541-X

Identification and expansion of the tumorigenic lung cancer stem cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0541-X

The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0541-X

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-013-0541-X

Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma

1 reference

12 December 2020

[Association of CD133 and endothelin-converting enzyme expressions with prognosis of non-small cell lung carcinoma]

1 reference

12 December 2020

CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors

1 reference

12 December 2020

A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning.

1 reference

12 December 2020

Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells

1 reference

12 December 2020

CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients

1 reference

12 December 2020

Identification of CD133+/nestin+ putative cancer stem cells in non-small cell lung cancer

1 reference

12 December 2020

Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter

1 reference

12 December 2020

Prognostic value of CD133 expression in stage I lung adenocarcinomas

1 reference

12 December 2020

1 reference

12 December 2020

The combination of stem cell markers CD133 and ABCG2 predicts relapse in stage I non-small cell lung carcinomas

1 reference

12 December 2020

10.1007/S10147-013-0541-X

Identifiers

DOI

1 reference

Dimensions Publication ID

24 November 2017

0 references

1 reference